2017
DOI: 10.1248/bpb.b17-00075
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, and Structure–Activity Relationship Study of Epoxysuccinyl–Peptide Derivatives as Cathepsin B Inhibitors

Abstract: Cathepsin B is a lysosomal cysteine protease involved in many diseases. The present research demonstrates that derivatives of epoxysuccinyl-peptide are effective and selective cathepsin B inhibitors. We synthesized a series of epoxysuccinyl-peptide derivatives based on the well-known cathepsin B inhibitor E64d. Specifically, we substituted the 2-methylpropane group at the R 1 position of E64d with a sulfane, such as ethyl(methyl) sulfane or benzyl(methyl) sulfane. We also designed and synthesized a library of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…E-64D, a widespread cysteine protease inhibitor derived from a natural fungal product, has been investigated for myotonic dystrophy treatment. However, it has not demonstrated success in human clinical trials, despite ongoing research for its potential application in spinal cord injury, stroke, and Alzheimer’s disease [ 40 ]. Given its history of use in treating several diseases, we speculated on its potential as a drug for avian trichomoniasis.…”
Section: Discussionmentioning
confidence: 99%
“…E-64D, a widespread cysteine protease inhibitor derived from a natural fungal product, has been investigated for myotonic dystrophy treatment. However, it has not demonstrated success in human clinical trials, despite ongoing research for its potential application in spinal cord injury, stroke, and Alzheimer’s disease [ 40 ]. Given its history of use in treating several diseases, we speculated on its potential as a drug for avian trichomoniasis.…”
Section: Discussionmentioning
confidence: 99%
“…Boc‐Met‐NHHex (2 h) . White solid (2.12 g, 95%); R f =0.5 (EtOAc : Hexane=1 : 9); 1 H NMR (300 MHz, CDCl 3 ): δ 0.87 (t, J =6.9, 3H, n Hex‐CH 3 ), 1.22–1.35 (m, 6H, n Hex‐CH 2 ×3), 1.43 (s, 9H, C(CH 3 ) 3 ), 1.46–1.51 (m, 2H, NHCH 2 CH 2 ), 1.85–2.16 (m, 2H, Hβ), 2.10 (s, 3H, SCH 3 ), 2.45–2.62 (m, 2H, Hγ), 3.24 (td, J =6.6, 6.3, 2H, NHCH 2 ), 4.21 (td, J =7.5, 7.4, 2H, Hα), 5.18–5.20 (br.…”
Section: Methodsmentioning
confidence: 99%
“…[31] One of the most encountered reactive groups of mechanism based ABP targeting papain family of the cysteine proteases is the epoxide which has been shown to label this type of enzyme efficiently and selectively. [32][33][34][35][36][37][38][39][40][41][42] The epoxide forms a thioether bond, irreversibly modifying the active site (Figure 1). [26,38,39,43,44] The origin of the epoxide "warhead" in the form of epoxysuccinates stems from the natural product E-64 (l-trans-epoxysuccinyl-leucylamido(4-guanidino)butane), which was initially isolated in 1978, from Aspergillus japonicus TPR-46 by Hanada and coworkers.…”
Section: Introductionmentioning
confidence: 99%
“…One of the most encountered reactive groups of mechanism based ABP targeting papain family of the cysteine proteases is the epoxide which has been shown to label this type of enzyme efficiently and selectively [32–42] . The epoxide forms a thioether bond, irreversibly modifying the active site (Figure 1).…”
Section: Introductionmentioning
confidence: 99%